We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTM
676
ZoomInfo Technologies
GTM
$978M
$946K 0.01%
41,585
+8,359
+25% +$215K
RDY icon
677
Dr. Reddy's Laboratories
RDY
$9.85B
$943K 0.01%
90,000
+20,000
+29% +$216K
TDOC icon
678
Teladoc Health
TDOC
$1.19B
$930K 0.01%
39,019
-15,560
-29% -$416K
HEI.A icon
679
HEICO Corp Class A
HEI.A
$35.8B
$928K 0.01%
7,420
+2,210
+42% +$293K
CTIC
680
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$928K 0.01%
240,000
+150,000
+167% +$779K
ROKU icon
681
Roku
ROKU
$21.5B
$927K 0.01%
15,297
-688
-4% -$40.3K
LEN icon
682
Lennar Class A
LEN
$20.2B
$887K 0.01%
9,473
-18,478
-66% -$1.78M
RGEN icon
683
Repligen
RGEN
$7.03B
$878K 0.01%
5,668
+2,113
+59% +$377K
TER icon
684
Teradyne
TER
$57.2B
$868K 0.01%
8,774
-5,846
-40% -$598K
ZM icon
685
Zoom
ZM
$27.1B
$864K 0.01%
12,708
+1,727
+16% +$124K
ENB icon
686
Enbridge
ENB
$121B
$850K 0.01%
24,266
+1,587
+7% +$62.3K
ATKR icon
687
Atkore
ATKR
$2.4B
$814K 0.01%
+6,299
New +$853K
NWSA icon
688
News Corp Class A
NWSA
$15.2B
$800K 0.01%
50,339
+3,847
+8% +$70.3K
CSL icon
689
Carlisle Companies
CSL
$15B
$796K 0.01%
3,826
+412
+12% +$100K
RCKT icon
690
Rocket Pharmaceuticals
RCKT
$351M
$788K 0.01%
50,000
CNQ icon
691
Canadian Natural Resources
CNQ
$98.6B
$783K 0.01%
30,798
-1,612
-5% -$45.7K
WYNN icon
692
Wynn Resorts
WYNN
$10.5B
$774K 0.01%
7,515
+2,004
+36% +$210K
DRI icon
693
Darden Restaurants
DRI
$23.7B
$772K 0.01%
5,403
+1,409
+35% +$208K
CLF icon
694
Cleveland-Cliffs
CLF
$6.64B
$747K 0.01%
+44,265
New +$877K
EQT icon
695
EQT Corp
EQT
$33B
$746K 0.01%
25,403
+7,271
+40% +$233K
GS icon
696
Goldman Sachs
GS
$302B
$731K 0.01%
2,427
-562
-19% -$196K
JBTM
697
JBT Marel
JBTM
$7.31B
$722K 0.01%
7,181
+2,328
+48% +$246K
WPM icon
698
Wheaton Precious Metals
WPM
$51.5B
$719K 0.01%
16,247
-1,469
-8% -$64.2K
LNN icon
699
Lindsay Corp
LNN
$1.12B
$719K 0.01%
+5,166
New +$781K
FMC icon
700
FMC
FMC
$1.48B
$711K ﹤0.01%
6,323

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.